معرفی
Lars Klemm is a Researcher and Laboratory Manager in the Müschen Lab at the Yale School of Medicine, part of Yale University. He holds an M.Sc. (2009) and B.Sc. (2006) from Heinrich-Heine-Universität Düsseldorf, Germany. His primary role involves managing the Müschen Lab, supporting experiments, and exploring new technologies for cancer research. His research focuses on leukemia pathogenesis, particularly B-cell malignancies, signaling pathways, and drug resistance mechanisms.
Key areas of investigation include understanding the molecular mechanisms of acute lymphoblastic leukemia (ALL), B-cell receptor signaling, and therapeutic targets. Collaborators include prominent researchers like Markus Müschen, David G. Schatz, and David Weinstock. Klemm has contributed to over 15 peer-reviewed publications since 2009, addressing topics such as SYK/ZAP70 signaling, integrin-mediated drug resistance, and epigenetic regulation in cancer.
His work integrates molecular biology, cell biology, and translational research to advance therapies for hematologic cancers. The Müschen Lab is affiliated with the Center of Molecular and Cellular Oncology, emphasizing interdisciplinary approaches to oncology.
